Recent Headlines
Within Biopharmaceuticals & Biotherapeutics

Specialty Enzymes | Alpha Amylase Enzyme for the Beverage Alcohol Industry

SEBstar-HTL | Improves Alcohol Production by Rapidly Gelatinizing Starches - October 15, 2010 - Specialty Enzymes and Biotechnologies Co

Carotech Announces Palm Fruit Bioactives Workshop to be Held Alongside SupplySide West, 2010

Palm fruit bioactives are increasingly utilized in dietary supplements, food & beverage as well as cosmetic & personal care products - October 14, 2010 - Carotech Inc.

Specialty Enzymes | Beneficial Brewing Enzyme Used for Quicker Maturation

| SEBmature L | Reducing the Maturation Time to Increase Brewery Production - October 09, 2010 - Specialty Enzymes and Biotechnologies Co

Adaptive Site Monitoring Improves Clinical Research Efficiency: DIA Invites Health Decisions to Discuss

Health Decisions CEO Dr. Michael Rosenberg will explore the implications of advanced e-monitoring models during two sessions at the DIA 4th Annual Clinical Forum. - October 08, 2010 - Health Decisions

AnaSpec Introduces BAFF Protein

AnaSpec is pleased to announce the release of a recombinant human BAFF protein. Naïve B-cells, treated with 20-1000 ng/ml BAFF protein prepared by AnaSpec, has been showing increased IgG secretion compared to 2 leading commercial sources. BAFF (BlyS, TALL-1, THANK, TNFSF13B, zTNF4) belongs to... - October 07, 2010 - AnaSpec, EGT Group

RayBiotech and Gentel Partner to Offer Comprehensive Selection of Arrays on APiX Chromogenic Detection Platform

RayBiotech, Inc., a pioneer and leader in protein and antibody array technologies, and Gentel Biosciences, a leader in proteomics profiling tools, jointly announced today their partnership to develop and market RayBiotech's vast collection of easy-to-use antibody array products for use with Gentel's APiX™ chromogenic detection platform, a cost-effective alternative to laser fluoresecence scanners. - October 05, 2010 - RayBiotech, Inc

Health Decisions CEO to Address Adaptive Patient Enrollment at Achieving Operational Efficiency in Clinical Trials 2010

Dr. Michael Rosenberg will discuss how continuously adapting enrollment during studies prevents delays and setbacks. - October 03, 2010 - Health Decisions

Specialty Enzymes | SEBamyl GL | New Brewing Enzyme and Beverage Alcohol Enzyme Manufacturer

SEBamyl-GL Improves Alcohol Production by Producing More Fermentable Sugars from Liquefied Starch Sources. - October 03, 2010 - Specialty Enzymes and Biotechnologies Co

AnaSpec Introduces MESA BLUE qPCR Mixes for SYBR® Assay

AnaSpec has introduced Eurogentec’s MESA BLUE qPCR MasterMix Plus for SYBR® Assay. This MasterMix is a unique combination of our high-performance Hotstart MeteorTaq and an inert BLUE dye. The BLUE dye, which does not affect the qPCR reaction, considerably enhances the contrast between the... - September 30, 2010 - AnaSpec, EGT Group

OSO BioPharmaceuticals Appoints Susan Schniepp VP of Quality

OSO BioPharmaceuticals Manufacturing, LLC, has named Susan Schniepp as vice president of quality. In managing all operational quality-related issues, Schniepp is responsible for cGMP compliance of OsoBio’s facility. Quality-related matters concerning validation as well as regulatory affairs,... - September 30, 2010 - OSO BioPharmaceuticals Manufacturing, LLC

AnaSpec Introduces First FRET-Based Cathepsin B Assay

AnaSpec is pleased to announce the release of the SensoLyte® 520 Cathepsin B Activity Assay Kit, the industry’s first FRET-based kit for Cathepsin B. This homogeneous assay can be used for measuring Cathepsin B activity and for screening Cathepsin B inhibitors. The substrate employs in... - September 22, 2010 - AnaSpec, EGT Group

AnaSpec Introduces Histone GO® Peptides

AnaSpec, the world’s largest provider of on-demand GO® peptides has introduced a wide selection of Histone H1, H2A, H2B, H3 and H4 peptides, especially the H3 peptides. The rapidly expanding Histone H3 GO ® Peptides include sequences that are acetylated, mono-, di- or tri-methylated,... - September 16, 2010 - AnaSpec, EGT Group

AnaSpec Introduces the Release of Mant-ATP and Mant-GTP

AnaSpec is pleased to announce the release of Mant-ATP and Mant-GTP. - September 14, 2010 - AnaSpec, EGT Group

F2G Ltd Announces the Appointment of Michael R. Hodges, M.D. to the Board of Directors

F2G Limited, the UK based antifungal drug discovery and development company, today announced the appointment of Dr Michael R. Hodges to the Company’s Board of Directors. Michael R Hodges, M.D., BSc., MRCP (UK) has 20 years of biopharmaceutical development experience and has worked in both... - September 13, 2010 - F2G Ltd

Synpromics: Scotland’s Latest Biotech Company

Synpromics announces its incorporation as Scotland’s latest biotech company. The new company aims to focus its activities in the area of synthetic biology and has acquired its patents from its managing director; Dr Michael Roberts. - September 12, 2010 - Synpromics Ltd

AnaSpec Signs Distribution Agreement with Interprise Brasil

AnaSpec, Inc. and Interprise Brasil today announced a non-exclusive distributor agreement that will allow Interprise Brasil to distribute AnaSpec’s catalog and custom products throughout Brasil. - August 28, 2010 - AnaSpec, EGT Group

Bio-Med QC Offers an Indiana Pharmacy Exclusive

Bio-Med QC has recently designed the most comprehensive and the most effective CSP quality assurance microbiology system available. The Bio-Shield AT system includes added value, on site training and saves you money over the alternative options that provide no microbiology support. Bio-Med QC has... - August 26, 2010 - Bio-Med QC

AnaSpec Visits with Noted Alzheimer’s Researcher, Dr. Patrick McGeer

AnaSpec’s general manager, Dr. Anita Hong and technical support specialist, Cecilia Po, visited the highly published and eminent Alzheimer’s researcher, Dr. Patrick McGeer and his associate, Dr. Jian-Ping Guo at the University of British Columbia, Vancouver, Canada on Aug. 12, 2010. - August 22, 2010 - AnaSpec, EGT Group

The Porcine microRNAome is Revealed

Results blaze a trail for advancement in pig biology as well the use of pigs as model organism for human biological and biomedical studies - August 20, 2010 - LC Sciences LLC

AnaSpec Introduces SensoLyte® Biotin Quantitation Assay Kit

AnaSpec is pleased to announce the release of the FRET based biotin quantitation kit. The SensoLyte® Biotin Quantitation Assay Kit provides a convenient way to estimate the efficiency of biotinylation for biotin-protein conjugates. The kit also can be used in quantitate biotin concentration in a solution. - August 20, 2010 - AnaSpec, EGT Group

CHI’s BioPharma Strategy Series Presents the Inaugural Mitigating Safety Risks in Early Clinical Development Executive Forum November 8-9, 2010, Philadelphia, PA

Presentations Discuss Bridging the Gap Between Pre-Clinical and Clinical Safety to Improve Prediction. - August 20, 2010 - Cambridge Healthtech Institute

AnaSpec Introduces Speedy 28-Day Antibody Service

AnaSpec introduces the Speedy 28-day custom polyclonal antibody service. Leveraging proven technology from Eurogentec, AnaSpec's parent company, this protocol uses a proprietary mixture of Freund's free immuno-stimulatory compounds. The first bleed, obtained at the accelerated rate of Day 21 after... - August 11, 2010 - AnaSpec, EGT Group

Health Decisions Appoints New CTO to Streamline Its HD360° Trial Management Platform

CRO hires Bryan Minihan to boost data integration and flow, providing sponsors and sites with a one-stop web portal for near real-time study information. - July 24, 2010 - Health Decisions

AnaSpec’s Published References Pass 1000

As compiled by Stanford University’s Highwire Press, the number of published papers that cite AnaSpec’s products has passed 1000. Products cited include AnaSpec’s custom and catalog peptides, antibodies, assay kits, dyes, standard amino acids, unusual amino acids and synthesis... - July 21, 2010 - AnaSpec, EGT Group

Wockhardt Foundation Achieves Another Milestone - Over 200 Cleft Surgeries in Association with Smile Train

Wockhardt Foundation, in collaboration with Smile train has successfully completed over 200 surgeries. - July 18, 2010 - Wockhardt Foundation

200,000 Patients Screened by Wockhardt Foundation Within 200 Days

Wockhardt Foundation screens over 200,000 patients. - July 18, 2010 - Wockhardt Foundation

InnoCore and Nanomi Strengthen Collaboration in Microsphere Technology for Peptide and Protein Delivery

InnoCore Technologies BV and Nanomi BV announce a strategic collaboration for the development of advanced monodisperse biodegradable microsphere-based controlled release formulations for the sustained delivery of biotherapeutics. - July 14, 2010 - Nanomi

The NIH Awards Aciont® a Small Business Catalyst Award Grant Accelerating Innovative Research

Aciont is awarded a phase I SBIR $214K grant for the project titled “Novel Method for the Ocular Iontophoretic Delivery of Avastin® and Lucentis®.” - July 08, 2010 - Aciont Inc.

Consumers Report Positive Results in Reducing Symptoms of Lactose Intolerance with Lactagen

Customer Experience Reports indicate relief from the symptoms of lactose intolerance using the Lactagen® program of colonic adaptation. - July 02, 2010 - Lactagen

Stemedica Announces the Appointment of Dr. Cesar Amescua Garcia as Medical and Regulatory Affairs Director – Latin America

Dr. Amescua will be responsible for liaison with regulatory agencies in Latin America regarding approvals of Stemedica’s allogeneic adult stem cell products for use in clinical (human) trials which follow the criteria required by the FDA in the United States. - July 02, 2010 - Stemedica Cell Techechnologies

Wockhardt Foundation Awarded ‘Pharma CSR Organization of the Year 2010’

Wockhardt Foundation wins the CSR award under the leadership of Huzaifa Khorakiwala who through his Human Values has created a team of dedicated warriors to work towards the upliftment of the poor weak and needy. - July 02, 2010 - Wockhardt Foundation

The 5th BIO KOREA 2010, Korea’s Largest Exhibition & Conference, on Biotech in Seoul, 1-3 September

The 5th BIO KOREA 2010 Conference & Exhibition will be held from September 1 to 3, 2010 at COEX in Seoul/Korea. BIO KOREA of this year offers a variety of high-level conference, international exhibition and partnership events and provides an opportunity to find business and technology partners. It expects to 265 companies and about 19,000 visitors from across the globe. - June 29, 2010 - Bio Korea

Functional Genetics Announces Two Separate Awards from the National Institute of Allergy and Infectious Diseases to Develop Broad Spectrum Antivirals

Functional Genetics, Inc. today announced the awarding of two different Phase II SBIR awards from the National Institute of Allergy and Infectious Diseases (NIAID) to pursue innovative approaches for antibody-based targeting of infectious diseases. Under the terms of the agreement, Functional... - June 29, 2010 - Functional Genetics, Inc.

AnaSpec Introduces New SensoLyte® uPA & tPA Assay Kits

AnaSpec is pleased to introduce two plasminogen activator assay kits – the SensoLyte AFC Urokinase (uPA) Assay Kit and the SensoLyte AMC tPA Assay Kit. - June 19, 2010 - AnaSpec, EGT Group

BIOCIUS Life Sciences and BlueSky Biotech Extend Partnership, Provide Validated Enzymes Fully‐Validated SIRT1 Enhances Drug Discovery Investigation

BIOCIUS Life Sciences Inc., developers of the RapidFire® highthroughputmass spectrometry system, and BlueSky Biotech, service provider of discovery biologicals, today announced their collaboration to offer the industry’s only Sirtuin (SIRT, silent mating type information regulation... - June 18, 2010 - Blue Sky Biotech

AnaSpec Signs Distribution Agreement with Bioeasy Diagnostica

AnaSpec, Inc. and Bioeasy Diagnostica today announced a non-exclusive distributor agreement that will allow Bioeasy Diagnostica to distribute AnaSpec’s catalog and custom products throughout Brasil. AnaSpec’s Director of Sales & Marketing, Violeta Rajkovska, noted, “AnaSpec... - June 18, 2010 - AnaSpec, EGT Group

Advanced Cell Technology Awarded Broad Patent for Production of Retinal Pigment Epithelial Cells

This broad patent gives Advanced Cell Technology the opportunity to have a monopoly around embryonic stem cells derived from RPE cells. There are over 200 diseases and conditions which potentially be treated with RPE-derived cells. - June 18, 2010 - Advanced Cell Technology, Inc.

Wockhardt Foundation Celebrates Service Commitment Day on 5th & 7th June with Zest, Energy & Activities

Dedicated warriors of Wockhardt Foundation across all sites, celebrated Service Commitment Day on 5th & 7th of June, in a unique fashion. US operations in both Morton Grove Pharmaceuticals and Wockhardt USA New Jersey conducted a food drive for local food banks that serve the poor, weak &... - June 13, 2010 - Wockhardt Foundation

AsymmetRx Medical Signs Multi Year Agreement with Ventana Medical a Member of the Roche Group

AsymmetRx Medical, Inc. an Acton, MA based Biotechnology Company, announced the signing of a license agreement with Ventana Medical, A member of the Roche Group. This agreement provides Ventana with the exclusive license and distribution rights of their patented Prostate Cancer Diagnostic tool... - June 11, 2010 - AsymmetRx Medical, Inc.

Health Decisions CEO Explores Adaptive Monitoring Techniques for Late-Stage Clinical Studies in June 14 DIA Session

Dr. Michael Rosenberg will describe how fast access to metrics, flexible processes, and automated technology enable study monitors to increase efficiency - June 10, 2010 - Health Decisions

AnaSpec Introduces Rhodamine 110 Labeled GO® Peptides

Rhodamine 110 (Rh110)-labeled peptides are used in the study of a number of protease activity. - June 05, 2010 - AnaSpec, EGT Group

The Allogeneic Adult Stem Cells Company Announcing Appointment of Dr. Lev Verkh

Lev Verkh is now a part of Stemedica, the allogeneic adult stem cells manufacturing company for effective stem cell clinical trials, thus improving the life of humans. - June 05, 2010 - Stemedica Cell Techechnologies

Health Decisions Encourages DIA Attendees to Demand More Than the Industry’s 10% Rate of On-Time Enrollment in Clinical Trials (Booth 929)

CRO demonstrates techniques that reverse the tide of enrollment delays in clinical research. - May 29, 2010 - Health Decisions

AnaSpec Introduces New SensoLyte® GSH and GST Assay Kits

AnaSpec has introduced two new Glutathione (GSH) related kits - the SensoLyte® Glutathione Cellular Assay Kit and the SensoLyte® GST Activity Assay Kit to complement the colorimetric and fluorimetric SensoLyte® Total GSH assay kits. The SensoLyte® Glutathione Cellular Assay Kit... - May 28, 2010 - AnaSpec, EGT Group

Recent Headlines Within Biopharmaceuticals & Biotherapeutics

Recent Headlines
Within Biopharmaceuticals & Biotherapeutics